Literature DB >> 8234688

Atypical hyperplasia: frequency and mammographic and pathologic relationships in excisional biopsies guided with mammography and clinical examination.

P C Stomper1, S P Cholewinski, R B Penetrante, J P Harlos, T N Tsangaris.   

Abstract

PURPOSE: To ascertain the frequency and pathologic relationships of atypical hyperplasia in biopsy specimens obtained after clinical and mammographic examination.
MATERIALS AND METHODS: Clinical, mammographic, and histologic findings were prospectively correlated in 300 consecutive excisional biopsies.
RESULTS: Atypical hyperplasia was detected in 26 (17%) of 154 biopsies with benign findings and 19 (13%) of 146 biopsies with malignant findings overall (P > .05). The frequency of atypical hyperplasia was only 4% (two of 55 specimens) in clinically prompted biopsies with benign findings but 24% (24 of 99 specimens) in mammographically prompted biopsies with benign findings (P = .002), increasing to 31% (21 of 68 specimens) in benign microcalcifications and 40% (18 of 45 specimens) in benign microcalcifications associated with adenosis. Atypical hyperplasia was found most often within (16 [62%] of 26 cases) or adjacent to (nine [35%] of 26 cases) another lesion that prompted biopsy.
CONCLUSION: Most atypical hyperplasia is not a random finding in benign biopsy specimens but shows a statistically significantly greater frequency in association with microcalcifications detected with mammography only, especially those in areas of adenosis.

Entities:  

Mesh:

Year:  1993        PMID: 8234688     DOI: 10.1148/radiology.189.3.8234688

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Surgical biopsy findings in patients with atypical hyperplasia diagnosed by stereotaxic core needle biopsy.

Authors:  I Tocino; B M Garcia; D Carter
Journal:  Ann Surg Oncol       Date:  1996-09       Impact factor: 5.344

2.  Rates of atypical ductal hyperplasia have declined with less use of postmenopausal hormone treatment: findings from the Breast Cancer Surveillance Consortium.

Authors:  Tehillah S Menes; Karla Kerlikowske; Shabnam Jaffer; Deborah Seger; Diana L Miglioretti
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11       Impact factor: 4.254

3.  Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy.

Authors:  Byung Joo Chae; Ahwon Lee; Byung Joo Song; Sang Seol Jung
Journal:  World J Surg Oncol       Date:  2009-10-23       Impact factor: 2.754

4.  Cellular proliferative activity of mammographic normal dense and fatty tissue determined by DNA S phase percentage.

Authors:  P C Stomper; R B Penetrante; S B Edge; M A Arredondo; L E Blumenson; C C Stewart
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Image-guided core-needle breast biopsy is an accurate technique to evaluate patients with nonpalpable imaging abnormalities.

Authors:  G M Fuhrman; G J Cederbom; J S Bolton; T A King; J L Duncan; J L Champaign; D H Smetherman; G H Farr; R R Kuske; W M McKinnon
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

6.  Epithelial atypia in biopsies performed for microcalcifications. practical considerations about 2,833 serially sectioned surgical biopsies with a long follow-up.

Authors:  Isabelle de Mascarel; Gaëtan MacGrogan; Simone Mathoulin-Pélissier; Anne Vincent-Salomon; Isabelle Soubeyran; Véronique Picot; Jean-Michel Coindre; Louis Mauriac
Journal:  Virchows Arch       Date:  2007-06-06       Impact factor: 4.064

7.  Atypical Ductal Hyperplasia of the Breast on Core Needle Biopsy: Risk of Malignant Upgrade on Surgical Excision.

Authors:  Tiffany Sin Hui Bong; Jun Kiat Thaddaeus Tan; Juliana Teng Swan Ho; Puay Hoon Tan; Wing Sze Lau; Tuan Meng Tan; Jill Su Lin Wong; Veronique Kiak Mien Tan; Benita Kiat Tee Tan; Preetha Madhukumar; Wei Sean Yong; Sue Zann Lim; Chow Yin Wong; Kong Wee Ong; Yirong Sim
Journal:  J Breast Cancer       Date:  2022-02       Impact factor: 3.588

Review 8.  The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.

Authors:  Sarah E Pinder; Ian O Ellis
Journal:  Breast Cancer Res       Date:  2003-07-29       Impact factor: 6.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.